Skip to content

Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting

Montag Ist Fasten-Tag (German) - MIFT [Monday is Fasting Day]

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02253056
Acronym
MIFT
Enrollment
36
Registered
2014-10-01
Start date
2014-09-30
Completion date
2015-03-31
Last updated
2015-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

Fasting, Caloric Restriction, Focus is to observe effects of fasting in healthy volunteers.

Brief summary

The aim of this pilot study is to evaluate the effects of one regular fasting day per week over a total period of 8 weeks compared to a normal-eating habits among healthy volunteers.

Detailed description

Participants in the intervention group receive an initial group training for fasting. Then all participants will observe one fixed fasting day per week (monday) over a total period of eight weeks. Participants in the control group receive an initial group training for healthy diet according to current German guidelines (DGE). Moreover, they will receive the same offer as in the intervention group at the end of the 8-week study period. Until then the control group participants follow a regular healthy diet.

Interventions

OTHERFasting / Caloric Restriction
OTHERHealthy Diet

Sponsors

Immanuel Hospital, Berlin, Germany
CollaboratorUNKNOWN
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18 -65 yrs * written informed consent

Exclusion criteria

* severe chronic comorbidity * eating disorders * pregnancy * planed pregnancy * simultaneous participation in other trials

Design outcomes

Primary

MeasureTime frameDescription
Insulin-like growth factor 1 and brain-derived neurotrophic factorBaseline and after 8 weeksMeasurement of changes after 8 weeks

Secondary

MeasureTime frameDescription
Profile of mood states questionnaire: POMSBaseline, 8 weeks, 6 monthQuestionnaire
Anxiety and depression questionnaire: HADSBaseline, 8 weeks, 6 monthQuestionnaire
Flourishing questionnaireBaseline, 8 weeks, 6 monthQuestionnaire
Visual analogue scales and Likert-scalesBaseline, 8 weeks, 6 monthQuestionnaire
Quality of life questionnaire: WHO-5Baseline, 8 weeks, 6 monthQuestionnaire
Body weight and abdominal circumferenceBaseline, 8 weeksMeasurement of changes after 8 weeks
Systolic and diastolic bloodpressureBaseline, 8 weeksMeasurement of changes after 8 weeks
Blood: total cholesterol, LDL, HDL, Triglycerides; Insulin, GOT,GPT, GGT, AP; HbA1c; PTT, INRBaseline and 8 weeksChanges after 8 weeks
Body Impedance Analysis (BIA)Baseline, 8 weeksMeasurement of changes after 8 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026